Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jan 22, 2024 (3 years ago)

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

Affected NDC 71139-0190-01

Compare with the code on your package — it is the most precise check available.

Drug: Vasopressin

Recalling firm
IntegraDose Compounding Services LLC
NDC code
71139-0190-1
Origin
MN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0325-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Vasopressin recalls

See all
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9647-12 D-0819-2026
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9640-12 D-0811-2026
Class II · Moderate risk

Vasopressin Injection

Subpotent product in addition to having out-of-specification results for impurities.

Terminated Wrong potency / content American Regent, Inc. NDC 0517-1030-01 D-0507-2024

Other recalls by IntegraDose Compounding Services LLC

All 2024 recalls